The 16 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 53.00, with a high estimate of 114.00 and a low estimate of 20.00. The median estimate represents a +46.13% increase from the last price of 36.27.
The current consensus among 21 polled investment analysts is to Buy stock in Ionis Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.47
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.